Johnson & Johnson
New York Stock ExchangeTotal Valuation
Johnson & Johnson carries a market capitalization of 575.52B, placing it among publicly traded companies globally. Its enterprise value stands at 621.40B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 575.52B |
| Enterprise Value | 621.40B |
Share Statistics
Johnson & Johnson currently has 2.41B shares outstanding.
| Shares Outstanding | 2.41B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Johnson & Johnson trades at a trailing price-to-earnings ratio of 27.97. The price-to-sales ratio is 6.11, and the price-to-book ratio stands at 188.61.
| PE Ratio | 27.97 |
| PS Ratio | 6.11 |
| PB Ratio | 188.61 |
| P/TBV Ratio | -35.81 |
| P/FCF Ratio | 20.99 |
| P/OCF Ratio | 25.73 |
Enterprise Valuation
On an enterprise value basis, Johnson & Johnson trades at an EV/EBITDA multiple of 18.53 and an EV/FCF ratio of 21.28. The EV/Sales ratio of 6.45 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 24.09 provides insight into valuation relative to core operating earnings.
| EV / Sales | 6.45 |
| EV / EBITDA | 18.53 |
| EV / EBIT | 24.09 |
| EV / FCF | 21.28 |
Financial Position
Johnson & Johnson maintains a current ratio of 1.03, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 67.73, indicating elevated leverage, while an interest coverage ratio of 32.27 demonstrates strong ability to service its debt obligations.
| Current Ratio | 1.03 |
| Quick Ratio | 0.77 |
| Debt / Equity | 67.73 |
| Debt / EBITDA | 1.64 |
| Interest Coverage | 32.27 |
Financial Efficiency
Johnson & Johnson posts a return on equity of 674.36 and a return on invested capital of 16.03.
| Return on Equity (ROE) | 674.36 |
| Return on Assets (ROA) | 10.66 |
| Return on Invested Capital (ROIC) | 16.03 |
| Return on Capital Employed (ROCE) | 38.63 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.28 |
Taxes
Over the trailing twelve months, Johnson & Johnson has paid 3.90B in income taxes, reflecting an effective tax rate of 15.64.
| Income Tax | 3.90B |
| Effective Tax Rate | 15.64 |
Stock Price Statistics
Johnson & Johnson's stock has gained approximately 57.9963% over the past 52 weeks. The 50-day moving average sits at 230.17, while the 200-day moving average is 216.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | 57.9963% |
| 50-Day Moving Average | 230.17 |
| 200-Day Moving Average | 216.00 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Johnson & Johnson generated 96.36B in revenue and converted that into 21.04B in net income, yielding earnings per share of 8.65. EBITDA reached 33.53B, while operating income came in at 25.79B.
| Revenue | 96.36B |
| Gross Profit | 65.36B |
| Operating Income | 25.79B |
| Pretax Income | 24.94B |
| Net Income | 21.04B |
| EBITDA | 33.53B |
| EBIT | 25.79B |
| Earnings Per Share (EPS) | 8.65 |
Balance Sheet
Johnson & Johnson holds 22.05B in cash and equivalents against 54.99B in total debt, resulting in a net debt position of 33.30B. Total book value stands at 3.12B, with working capital of 1.46B providing operational flexibility.
| Cash & Cash Equivalents | 22.05B |
| Total Debt | 54.99B |
| Net Debt | 33.30B |
| Equity (Book Value) | 3.12B |
| Book Value Per Share | 1.30 |
| Working Capital | 1.46B |
Cash Flow
Johnson & Johnson produced 22.87B in operating cash flow over the past twelve months. After subtracting -5.46B in capital expenditures, free cash flow totaled 17.41B - equivalent to 7.23 per share.
| Operating Cash Flow | 22.87B |
| Capital Expenditures | -5.46B |
| Free Cash Flow | 17.41B |
| FCF Per Share | 7.23 |
Margins
Johnson & Johnson operates with a gross margin of 67.82, reflecting its pricing power and cost economics. The operating margin of 26.77 and net profit margin of 21.83 provide insight into operational efficiency.
| Gross Margin | 67.82 |
| Operating Margin | 26.77 |
| Pretax Margin | 25.88 |
| Profit Margin | 21.83 |
| EBITDA Margin | 34.79 |
Dividends & Yields
The company's payout ratio of 59.52 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 5.20 |
| Dividend Yield | N/A |
| Payout Ratio | 59.52 |
| Shareholder Yield | 2.62 |
| FCF Yield | 4.76 |
Stock Splits
Johnson & Johnson's most recent stock split took place on June 13, 2001 with a 1:2 split ratio.
| Last Split Date | 6/13/2001 |
| Split Ratio | 1:2 |
Scores
Johnson & Johnson posts an Altman Z-Score of 4.72, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.72 |